Wednesday, April 23, 2025
spot_img

Equinor ASA: Buy-back of shares to share programmes for employees

Please see below information about transactions made under the buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR) for shares to be used in the share-based incentive programmes for employees and management.

Date on which the buy-back programme was announced: 5 February 2025.

The duration of the buy-back programme: 14 February 2025 to 15 January 2026.

Size of the buy-back programme: The total purchase amount under the programme is NOK 1,992,000,000 and the maximum shares to be acquired is 19,080,000 shares, of which up to 8,040,000 shares can be acquired in the period from 14 February 2025 to 15 May 2025, and up to 11,040,000 shares can be acquired in the period from 16 May 2025 to 15 January 2026.

On 15 April 2025, Equinor ASA has purchased a total of 636,401 own shares at the Oslo Stock Exchange at an average price of NOK 248.2708 per share.

Aggregated overview of transactions per day:

Date      
       
15 April 2025 636,401 248.2708 157,999,785
       
Previously disclosed buy-backs under the programme (accumulated) 1,175,018 257.0172 301,999,804
       
Total buy-backs under the programme 1,811,419 253.9443 459,999,589

 
Following the completion of the above transactions, Equinor ASA owns a total of 86,149,757 own shares, corresponding to 3.08% of Equinor ASA’s share capital, including shares purchased under the previous buy-back programme for the share-based incentive programmes for employees, and shares purchased under Equinor’s disclosed buy-back programmes which will be used to reduce the issued share capital of the company.

This is information that Equinor ASA is obliged to make public pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.

Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

Further information from

Investor relations
BÃ¥rd Glad Pedersen, senior vice president Investor Relations,
+47 918 01 791

Media
Sissel Rinde, vice president Media Relations,
+47 412 60 584

Attachment

  • Equinor Employee share saving programme – 15 April 2025

Powered by SlickText.com

Hot this week

PRESS RELEASE: NACON’S REVOLUTION X UNLIMITED AVAILABLE NOW IN STORES

NACON’S REVOLUTION X UNLIMITED AVAILABLE NOW IN STORES ...

Transaction in Own Shares

Transaction in Own Shares 23 April, 2025 ...

NewtekOne, Inc. Closes ALP Loan Securitization with Sale of $184 Million of Rated Notes

Transaction Marks NewtekOne’s 16th SecuritizationBOCA RATON, Fla., April ...

Tonner Drones Obtains Patent For Inhibitor In The United States

Tonner Drones Obtains Patent For Inhibitor In The United...

Topics

PRESS RELEASE: NACON’S REVOLUTION X UNLIMITED AVAILABLE NOW IN STORES

NACON’S REVOLUTION X UNLIMITED AVAILABLE NOW IN STORES ...

Transaction in Own Shares

Transaction in Own Shares 23 April, 2025 ...

NewtekOne, Inc. Closes ALP Loan Securitization with Sale of $184 Million of Rated Notes

Transaction Marks NewtekOne’s 16th SecuritizationBOCA RATON, Fla., April ...

Tonner Drones Obtains Patent For Inhibitor In The United States

Tonner Drones Obtains Patent For Inhibitor In The United...

Amundi: Ordinary and Extraordinary general meeting of shareholders, 27th May 2025

Amundi : Ordinary and Extraordinary general meeting of shareholders,...

OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025

OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO...
spot_img

Related Articles

Popular Categories

spot_img